跳至主要内容
临床试验/ACTRN12620001081909
ACTRN12620001081909尚未招募未知

Exercise medicine as chemotherapy adjunct: the feasibility and efficacy of a multi-component program in pancreatic cancer patients receiving neoadjuvant therapy (The EXPAN Project)

Edith Cowan University0 个研究点目标入组 40 人开始时间: 2020年10月20日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients diagnosed with borderline resectable or locally advanced pancreatic adenocarcinoma as per the definition proposed by the Australasian Gastro-Intestinal Trials Group and waiting to commence or within four weeks after starting their prescribed chemotherapy

排除标准

  • - Treatment for another primary cancer within the last 12 months, or another ongoing active primary malignancy;
  • - Recurrent pancreatic cancer with or without exposure to previous chemotherapy
  • - Anticipating to undergo major surgery for non-cancer diseases within six months
  • - Participating in structured exercise training greater than or equal to 2 days/week in the previous month
  • - ECOG (Eastern Cooperative Oncology Group) performance score greater than 1
  • - Contraindications to exercise training at moderate intensity

研究者

相似试验